Below are the details for the FACT-HN measure:
Functional Assessment of Cancer Therapy – Head & Neck (FACT-HN)
NUMBER OF ITEMS:
Head & neck cancer patients 18 years and older
Past 7 days
5 point Likert-type scale
Paper and electronic
Self-administration and interview when applicable
Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Head & Neck Cancer Subscale
TIME FOR COMPLETION:
Manual scoring template, some items are reverse scored. Subscale scores, total scores and TOI scores possible. SAS/SPSS algorithms available.
Available translations of the FACT-HN can be obtained by registering for permission. Users are not permitted to translate the FACT-HN without permission from FACIT.org. Permission from FACIT.org to translate the FACT-HN may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system.
Please contact us for more information.
Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.
Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.
To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.
D'Antonio, L., Zimmerman G., Cella, D., & Long, S. Quality of life and functional status measures in patients with head and neck cancer. Archives of Otolaryngology-Head & Neck Surgery 1996; 122: 482-487.
List, M.A., D'Antonio, L.L., Cella, D.F., Siston, A., Mumby, P., Haraf, D., & Vokes, E. The Performance Status Scale for Head and Neck Cancer (PSS-HN) and the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) Scale: A study of utility and validity. Cancer1996; 77(11): 2294-2301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S.
Reeve, B., Cai, J., Zhang, H., Choi, J., Weissler, M., Cella, D., & Olshan, A. Health-related quality of life differences between African-Americans and Non-Hispanic whites with head and neck cancer. Head and Neck2013; 35(9): 1255-64. doi: 10.1002/hed.23115.
Ringash J, Lockwood G, O'Sullivan B, Warde P, Bayley A, Cummings B, Kim J, Sellmann S, & Waldron J. Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 2008; 87(2):181-187. doi: 10.1016/j.radonc.2007.12.028.
Ringash, J., Bernstein, L, Cella, D., Logemann, J., Movsas, B., Murphy, B., Trotti, A., Wells, N., Yueh, B., & Ridge, J. Outcomes toolbox for head and neck cancer research. Head & Neck 2015; 37(3): 425-39. doi: 10.1002/hed.23561.
Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320.
Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232.
Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85.
Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191.